Indication
Sleep Fragmentation
1 clinical trial
2 products
Clinical trial
Effects of the Orexin Receptor Antagonist Suvorexant on Sleep Architecture and Delirium in the Intensive Care Unit: A Multi-Centric Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-12-31
Product
SuvorexantProduct
Placebo